Coronary artery bypass grafting (CABG) without cardiopulmonary bypass achieves lower hospital mortality rates than the conventional method that employs bypass, according to […]
Objective: Maintenance of normothermia during cardiopulmonary bypass (CPB) may have advantages over hypothermia but there is a potential increased hazard of neurological […]
Ferric carboxymaltose (FCM) is a nondextran iron preparation recently approved in the United States for intravenous treatment of iron deficiency anemia (IDA) in adult patients with intolerance or unsatisfactory response to oral iron or with nondialysis-dependent chronic kidney disease.
